Table 3 Listing of all persistent and temporary non-synonymous mutations that the strain has accumulated over the 7-month study period.

From: Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host

 

n total

VOC/VOI

[%]

n in spike

VOC/VOI

%

Acquired non-synonymous mutations:

22

17

[77.3]

17

15

[88.2]

Persistent non-synonymous mutations:

11

8

[72.7]

9

8

[88.9]

Temporary non-synonymous mutations:

11

9

[81.8]

8

7

[87.5]

  1. n total, number of all non-synonymous intra-host acquired mutations; n in spike, number of all non-synonymous intra-host acquired mutations in the spike-coding region; VOC/VOI, number of mutations that are found in comparable expression in a variants of concern (VOC) or a variant of interest (VOI). Source data are provided as a Source Data file.
Back to article page